Navigation Links
Johnson & Johnson Ethicon Transvaginal Mesh Lawsuits Update: Resource4thePeople Reports Judge Schedules More Trials for This Summer
Date:4/6/2013

San Diego, CA (PRWEB) April 06, 2013

http://www.resource4thepeople.com/defectivemedicaldevices/transvaginal-mesh-lawsuit.html

Resource4thePeople is updating consumers interested in lawsuits involving serious side effects from transvaginal mesh products today by reporting that additional cases involved in federal multi-district litigations are advancing to trials.

A judge in the Southern District Court of Virginia, for instance, has recently issued an order formalizing the selection of four lawsuits from that judge’s multi-district litigation as bellwether trials to move forward on July 11.*

Those cases involve allegations that C.R. Bard’s Avaulta mesh products that were implanted in women’s bodies to treat pelvic organ prolapse or incontinence failed and caused them to suffer serious side effects, including infections, organ damage, vaginal pain and other health problems, according to the court files.*

The cases are one of several multi-district litigations involving transvaginal mesh, including one in New Jersey in which Bloomberg News reported** that a jury awarded over $11 million in compensatory and damages to a South Dakota woman and her husband in a transvaginal mesh lawsuit trial.

Resource4thePeople said that the total verdict of $11.1 million against pharmaceutical giant Johnson & Johnson and its Ethicon subsidiary has generated such a significant number of inquiries from transvaginal mesh patients that additional lawyers now will be available to assist other women who have suffered similar complications.

"This was an important case because it was the first to be heard by a jury among over 2,000 other lawsuits that made similar allegations about transvaginal mesh products manufactured by Johnson & Johnson and its subsidiary, Ethicon," said Resource4thePeople.

Resource4thePeople has been providing a steady stream of referrals to free legal consultations by a national network of lawyers on cases involving transvaginal mesh complications.

"The fact that the jury decided that punitive damages, which are an option of a jury to punish a defendant for its behavior, is an important factor that may affect whether Johnson & Johnson decides to settle the many other cases it faces or face more trials."

"With this verdict the flow of inquiries is increasing and we will be adding additional lawyers to our nationwide legal network in order to provide all consumers with access to experienced, aggressive advice about the legal options that other victims of these products may have available to them."

The South Dakota woman's lawsuit*** was the first to go to trial from among 2,100 lawsuits consolidated in New Jersey over allegations that the companies' vaginal mesh products were not safe and that consumers were not warned of dangerous side effects.

Bloomberg News reported that lawyers for the woman, Linda Gross, asked jurors in Atlantic City to require Johnson & Johnson, the world’s largest seller of health-care products, to pay punitive damages after the panel found the company failed to warn the woman's surgeon of the risks of its Gynecare Prolift implant and fraudulently misled her about the risks.****

"New Jersey caps punitive damages at five times compensatory damages, or $16.75 million, although jurors weren’t told that," Bloomberg reported, saying that " Gross attorney Adam Slater urged the panel of six women and three men to find that J&J and its Ethicon unit acted with willful and wanton disregard of the probable harm to his client."

According to the court file in the case, the 47-year-old Gross filed allegations complaining of constant pain and said she was forced to undergo 18 operations to repair abdominal injuries she suffered after having the device implanted to treat her pelvic organ prolapse.

Bloomberg reported that Gross’s attorneys called a forensic economics expert, Frank Tinari, to testify about J&J’s financial condition and he testified the company, he said, had total assets of $121.3 billion and a net worth of $64.8 billion through Dec. 31.

"Among the questions we are receiving from women who suffered transvaginal mesh implants are whether it is too late to file a lawsuit on their behalf," said Resource4thePeople.

"The answer, in most cases, is no. There is also the possibility that now that Johnson & Johnson and Ethicon have been found liable for damages that they may become more amenable to settling claims filed against them rather than going to trial again."

"Each case is different of course, which is why we recommend that any woman who has suffered serious health problems as a result of transvaginal mesh seek out legal advice to define their eligibility to seek compensation."

Resource4thePeople also is recommending that women who have suffered health problems from transvaginal mesh products familiarize themselves with Safety Communications issued by the Food and Drug Administration warning of “serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse."*****

In the warning issued to health care professionals, the FDA cited recent medical literature which revealed that:

  • Mesh used in transvaginal POP repair introduces risks not present in traditional non-mesh surgery for POP repair.
  • Mesh placed abdominally for POP repair appears to result in lower rates of mesh complications compared to transvaginal POP surgery with mesh.
  • There is no evidence that transvaginal repair to support the top of the vagina (apical repair) or the back wall of the vagina (posterior repair) with mesh provides any added benefit compared to traditional surgery without mesh.
  • While transvaginal surgical repair to correct weakened tissue between the bladder and vagina (anterior repair) with mesh augmentation may provide an anatomic benefit compared to traditional POP repair without mesh, this anatomic benefit may not result in better symptomatic results.

Sources:
*In Re Avaulta Pelvic Support Systems Products Liability Litigation MDL #2187, U.S. District Court, Southern District of Virginia
** http://www.bloomberg.com/news/2013-02-28/j-j-owes-7-76-million-in-punitives-in-vaginal-mesh-case.html
***Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey (Atlantic City)
****http://www.bloomberg.com/news/2013-02-26/j-j-seeks-to-avoid-punitives-after-losing-mesh-verdict.html
*****http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435

Read the full story at http://www.prweb.com/releases/2013/4/prweb10594898.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Johnson & Johnson Violated FDA Order to Halt Sales of Transvaginal Mesh
2. Results from study of Mead Johnsons Enfamil® Human Milk Fortifier Acidified Liquid published in Pediatrics
3. The US Drug Watchdog Now Urges Women Who Suffered A Heart Attack Or Stroke After Using Yaz Yasmin Birth Control Pills To Contact The Johnson Law Group Immediately
4. The US Drug Watchdog Now Urges Any Woman Who Used The Birth Control Pills Yaz Or Yasmin And Then Had A Heart Attack Or Stroke To Call The Johnson Law Group----ASAP
5. US Drug Watchdog Now Urges Women Who Used Yaz or Yasmin Birth Control Pills and Had a Heart Attack or Stroke to Call The Johnson Law Group immediately-Get Identified Now
6. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or a Heart Attack to Call the Johnson Law Group Now-Before Time Runs Out
7. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
8. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
9. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Stroke, Blood Clots, or a Heart Attack to Call the Johnson Law Group for a Legal Review
10. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
11. US Drug Watchdog Now Fears Most Women Never Heard About Yaz or Yasmin Birth Control Pill Side Effects and They Urge to Victims to Call the Johnson Law Group-Get Help Now
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose ... in the Dallas area” Tuesday evening at the 26th Annual SMU Cox Dallas ... SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth ...
(Date:12/2/2016)... California (PRWEB) , ... December 02, 2016 , ... Halfway ... Dental Medicine has provided preventative dental services to more than 15,900 children 5 years ... First 5 LA pledged $38 million over a span of five years to Western ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... across the Dothan-Wiregrass Area in Alabama are expected to attend the UNCF Dothan-Wiregrass ... will help provide scholarship funds for area students and operating support to UNCF-member ...
(Date:12/2/2016)... ... , ... U.S. Surgeon General, Dr. Vivek Murthy, graces the cover of the ... inspired to practice medicine at an early age by his father, who was also ... and prescribing medicine,” he states. “It is about building relationships with people; relationships that ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is ... USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that ... “We are prolonging life 6 years in the last 3 decades,” says Dr. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... the largest share in the ECG Cables And ECG Leadwires ... remote monitoring ECG devices. On the other hand, the ... the highest growth rate during the forecast period. ... Company (U.S.), Medtronic plc ( Ireland ), Koninklijke ... Medical International Limited ( China ), held major ...
(Date:12/2/2016)... Research and Markets has announced the addition of the "Global ... report to their offering. ... , The global ultrasound device market ... to grow at a CAGR of 5.5% during 2016-2022. Based on portability, ... forecast period, a CAGR of 8.8% in the global market. Among the ...
(Date:12/2/2016)... , Dec. 2, 2016  PipelineRx, a leading medication ... be offering demonstrations of its SaaS-based telepharmacy platform, ... Health-System Pharmacists 2016 Midyear Clinical Meeting and Exhibition, ... . With nearly 300 hospital clients nationally, the ... technology designed to dramatically improve pharmacy operations, enhance ...
Breaking Medicine Technology: